Lexington Partners is leading the $1.2 billion secondary deal that will see Warburg Pincus sell a portion of every Asian investment in its 11th global fund in order to return capital to LPs. Goldman Sachs’ asset management arm is also participating as co-lead investor.
Capital has also been allocated for follow-on funding for certain companies. The deal – first reported by The Wall Street Journal and subsequently confirmed to AVCJ by sources familiar with the situation...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.